Q32 Bio Inc.

Nasdaq:QTTB

Pharmaceutical Preparations·WALTHAM, MA

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/10/26	→
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/6/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/11/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
↓

Earnings Releases (8-K)

11 shown

Filed	Period
3/10/26	Q1 FY2026	→
11/13/25	Q4 FY2025	→
8/6/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/11/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

48 shown

Filed	Type	Description
2/17/26	Agreement	Entry into a Material Definitive Agreement	→
12/19/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/1/25	Acquisition	Entry into a Material Definitive Agreement	→
10/21/25	Other	Other Events	→
6/25/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/17/25	Vote	Material Modification to Rights of Security Holders	→
↓

Prospectuses & Registrations

39 shown

Filed	Form	Description
3/10/26	S-8	S-8	→
2/17/26	424B5	424B5	→
4/29/25	ARS	ARS	→
4/11/25	S-3	S-3	→
3/11/25	S-8	S-8	→
3/11/25	424B3	424B3	→
↓

Filing History(513 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13D/A

Mar 12, 2026

0000947871-26-000245

—

23.0 KB

S-8

Mar 10, 2026

0001193125-26-099356S-8

—

170.3 KB

10-K

Mar 10, 2026

0001193125-26-09933910-K

Dec 31, 2025

17.2 MB

8-K

Mar 10, 2026

0001193125-26-0993288-K

Mar 10, 2026

409.1 KB

Feb 27, 2026

0001193125-26-0835884

Feb 25, 2026

5.1 KB

Feb 27, 2026

0001193125-26-0835854

Feb 25, 2026

5.1 KB

Feb 27, 2026

0001193125-26-0835844

Feb 25, 2026

6.3 KB

SCHEDULE 13G

Feb 20, 2026

0001493152-26-007650

—

22.3 KB

SCHEDULE 13G

Feb 19, 2026

0000902664-26-001202

—

20.4 KB

8-K

Feb 17, 2026

0001193125-26-0547118-K

Feb 17, 2026

478.8 KB

424B5

Feb 17, 2026

0001193125-26-054660424B5

—

634.7 KB

SCHEDULE 13G/A

Feb 13, 2026

0000078003-26-000020

—

8.2 KB

Jan 30, 2026

0001193125-26-0322484

Jan 15, 2026

5.5 KB

Jan 30, 2026

0001193125-26-0322474

Jan 15, 2026

6.1 KB

Jan 30, 2026

0001193125-26-0322464

Jan 15, 2026

5.5 KB

8-K

Dec 19, 2025

0001193125-25-3268218-K

Dec 17, 2025

129.2 KB

Dec 4, 2025

0001193125-25-3083284

Dec 2, 2025

4.3 KB

Dec 4, 2025

0001193125-25-3083274

Dec 2, 2025

4.3 KB

144

Dec 2, 2025

0001950047-25-009643

—

4.6 KB

144

Dec 2, 2025

0001950047-25-009608

—

4.6 KB

8-K

Dec 1, 2025

0001193125-25-3031158-K

Nov 28, 2025

172.1 KB

10-Q

Nov 13, 2025

0001193125-25-27881210-Q

Sep 30, 2025

11.3 MB

8-K

Nov 13, 2025

0001193125-25-2788058-K

Nov 13, 2025

373.9 KB

Oct 27, 2025

0001193125-25-2520004

Oct 23, 2025

5.2 KB

Oct 27, 2025

0001193125-25-2519944

Oct 23, 2025

5.1 KB

25 filings shown

Filed	Form	Description
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→
4/11/25	PRE 14A	PRE 14A	→
4/28/23	DEFA14A	DEFA14A	→
4/28/23	DEF 14A	DEF 14A	→
4/29/22	DEFA14A	DEFA14A	→
↓

Q32 Bio Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(513 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/27/26	4	4	→
2/27/26	4	4	→
2/27/26	4	4	→
1/30/26	4	4	→
1/30/26	4	4	→
1/30/26	4	4	→
↓

Filed	Form	Description
3/12/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/20/26	SCHEDULE 13G	SCHEDULE 13G	→
2/19/26	SCHEDULE 13G	SCHEDULE 13G	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/2/25	144	144	→
12/2/25	144	144	→
↓